{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:56:29Z","timestamp":1772844989460,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bio & Medical Technology Development Program of the NRF funded by the Korean government","award":["RS-2024-00440824"],"award-info":[{"award-number":["RS-2024-00440824"]}]},{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute","award":["RS-2024-00439685"],"award-info":[{"award-number":["RS-2024-00439685"]}]},{"name":"National Research Council of Science & Technology (NST) grant by the Korean government","award":["CAP23021-000"],"award-info":[{"award-number":["CAP23021-000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03687-4","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:18:22Z","timestamp":1740399502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic outcomes in non-alcoholic and alcoholic steatotic liver disease among Korean and American adults"],"prefix":"10.1186","volume":"25","author":[{"given":"Yeongmin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Sic","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Myung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"crossref","unstructured":"Kasper P, Martin A, Lang S, Kuetting F, Goeser T, Demir M. Steffen H-MJCric: NAFLD and cardiovascular diseases: a clinical review. 2021, 110:921\u201337.","DOI":"10.1007\/s00392-020-01709-7"},{"key":"3687_CR2","doi-asserted-by":"crossref","unstructured":"Li Z, Shen Y, Li Z, Cao D, Hu Y. Is MetALD an independent risk factor of all-cause mortality? A meta-analysis of 164,694 individuals from the real world. J Hepatol 2024.","DOI":"10.1016\/j.jhep.2024.10.022"},{"key":"3687_CR3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","volume":"22","author":"M Kalligeros","year":"2024","unstructured":"Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin M. Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017\u20132020. Clin Gastroenterol Hepatol. 2024;22:1330\u20132. e1334.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3687_CR4","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MAJNRG. Hepatology: Advancing the global public health agenda for NAFLD: a consensus statement. 2022, 19:60\u201378."},{"key":"3687_CR5","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JPJH. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. 2023, 78:1966\u201386."},{"key":"3687_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","volume":"8","author":"M Israelsen","year":"2023","unstructured":"Israelsen M, Torp N, Johansen S, Thiele M, Krag A. MetALD: new opportunities to understand the role of alcohol in steatotic liver disease. Lancet Gastroenterol Hepatol. 2023;8:866\u20138.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3687_CR7","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/liv.16034","volume":"44","author":"E Petrie","year":"2024","unstructured":"Petrie E, Gray M, Bril F. Metabolic characteristics of patients with MetALD: caveats of a new definition. Liver Int. 2024;44:2929\u201338.","journal-title":"Liver Int"},{"key":"3687_CR8","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/j.jhep.2023.08.021","volume":"80","author":"L Chen","year":"2024","unstructured":"Chen L, Tao X, Zeng M, Mi Y, Xu L. Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD. J Hepatol. 2024;80:e64\u20136.","journal-title":"J Hepatol"},{"key":"3687_CR9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/jcm13041158","volume":"13","author":"T Miwa","year":"2024","unstructured":"Miwa T, Tajirika S, Imamura N, Adachi M, Horita R, Hanai T, Fukao T, Shimizu M, Yamamoto M. Prevalence of steatotic liver disease based on a new nomenclature in the Japanese population: a health checkup-based cross-sectional study. J Clin Med. 2024;13:1158.","journal-title":"J Clin Med"},{"key":"3687_CR10","doi-asserted-by":"crossref","unstructured":"Ji L, Cai X, Bai Y, Li T. Application of a novel prediction model for predicting 2-year risk of non-alcoholic fatty liver disease in the non-obese population with normal blood lipid levels: a large prospective cohort study from China. Int J Gen Med 2021:2909\u201322.","DOI":"10.2147\/IJGM.S319759"},{"key":"3687_CR11","doi-asserted-by":"crossref","unstructured":"Kim Y, Han B-G. Epidemiology KGJIjo: cohort profile: the Korean genome and epidemiology study (KoGES) consortium. 2017, 46:e20\u201320.","DOI":"10.1093\/ije\/dyv316"},{"key":"3687_CR12","doi-asserted-by":"crossref","unstructured":"Oh K, Kim Y, Kweon S, Kim S, Yun S, Park S, Lee Y-K, Kim Y, Park O, Jeong EKJE. health: Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions. 2021, 43.","DOI":"10.4178\/epih.e2021025"},{"key":"3687_CR13","doi-asserted-by":"crossref","unstructured":"Yun S, Oh KJE. health: The Korea national health and nutrition examination survey data linked cause of death data. 2022, 44.","DOI":"10.4178\/epih.e2022021"},{"key":"3687_CR14","doi-asserted-by":"crossref","unstructured":"Lau DT, Ahluwalia N, Fryar CD, Kaufman M, Arispe IE, Paulose-Ram RJAJPH. Data Related to Social Determinants of Health Captured in the National Health and Nutrition Examination Survey. Volume 113. American Public Health Association; 2023. pp. 1290\u20135.","DOI":"10.2105\/AJPH.2023.307490"},{"key":"3687_CR15","doi-asserted-by":"crossref","unstructured":"Ale L, Gentleman R, Sonmez TF, Sarkar D, Endres CJD. nhanesA: achieving transparency and reproducibility in NHANES research. 2024, 2024:baae028.","DOI":"10.1093\/database\/baae028"},{"key":"3687_CR16","doi-asserted-by":"crossref","unstructured":"Priego-Parra BA, Triana-Romero A, Mart\u00ednez-P\u00e9rez GP, Reyes-Diaz SA, Ordaz-Alvarez HR, Bernal-Reyes R, Icaza-Ch\u00e1vez ME, Mart\u00ednez-V\u00e1zquez SE, Cano-Contreras AD. Vivanco-Cid HJAoH: hepatic steatosis index (HSI): a Valuable Biomarker in subjects with metabolic dysfunction-associated fatty liver Disease (MAFLD). 2024, 29:101391.","DOI":"10.1016\/j.aohep.2024.101391"},{"key":"3687_CR17","doi-asserted-by":"crossref","unstructured":"Chang JW, Lee HW, Kim BK, Park JY, Ahn SH, Han K-H, Kim SUJG. Liver: hepatic steatosis index in the detection of fatty liver in patients with chronic hepatitis B receiving antiviral therapy. 2021, 15:117.","DOI":"10.5009\/gnl19301"},{"key":"3687_CR18","doi-asserted-by":"crossref","unstructured":"Lee T, Chung T-HJSR. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass. 2023, 13:1645.","DOI":"10.1038\/s41598-023-28751-5"},{"key":"3687_CR19","doi-asserted-by":"publisher","first-page":"e13110","DOI":"10.1002\/jgh3.13110","volume":"8","author":"T Miwa","year":"2024","unstructured":"Miwa T, Tajirika S, Imamura N, Adachi M, Horita R, Hanai T, Ng CH, Siddiqui MS, Fukao T, Shimizu M. Usefulness of health checkup-based indices in identifying metabolic dysfunction\u2010associated steatotic liver disease. JGH Open. 2024;8:e13110.","journal-title":"JGH Open"},{"key":"3687_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/diagnostics11010132","volume":"11","author":"K Murayama","year":"2021","unstructured":"Murayama K, Okada M, Tanaka K, Inadomi C, Yoshioka W, Kubotsu Y, Yada T, Isoda H, Kuwashiro T, Oeda S. Prediction of nonalcoholic fatty liver disease using noninvasive and non-imaging procedures in Japanese health checkup examinees. Diagnostics. 2021;11:132.","journal-title":"Diagnostics"},{"key":"3687_CR21","doi-asserted-by":"crossref","unstructured":"Sinn DH, Kang D, Guallar E, Choi SC, Hong YS, Park Y, Cho J, Gwak G-YJP. Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: a longitudinal cohort study. 2023, 18:e0288820.","DOI":"10.1371\/journal.pone.0288820"},{"key":"3687_CR22","doi-asserted-by":"crossref","unstructured":"Shim YN, Choi HJ, Jung D, Jo MS, Oh HJJKJFP. Association between muscle mass deficits and the non-alcoholic fatty liver disease fibrosis score in adults without central obesity. 2021, 11:345\u201351.","DOI":"10.21215\/kjfp.2021.11.5.345"},{"key":"3687_CR23","doi-asserted-by":"crossref","unstructured":"Zhang Y, Shi R, Yu L, Ji L, Li M, Hu FJDT. Establishment of a risk prediction model for non-alcoholic fatty liver disease in type 2 diabetes. 2020, 11:2057\u201373.","DOI":"10.1007\/s13300-020-00893-z"},{"key":"3687_CR24","doi-asserted-by":"crossref","unstructured":"He X, Huang X, Qian Y, Sun TJFE. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis. 2023, 14:1188214.","DOI":"10.3389\/fendo.2023.1188214"},{"key":"3687_CR25","doi-asserted-by":"crossref","unstructured":"Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, Sheng G, Xie G, Zou YJJTM. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. 2023, 21:192.","DOI":"10.1186\/s12967-023-04047-0"},{"key":"3687_CR26","doi-asserted-by":"crossref","unstructured":"Qian Y, Sun B, Zhang Y, Zhang M, Jiao X, Lai L, Yang WJAPM. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study. 2022, 11:2349\u201359.","DOI":"10.21037\/apm-21-2988"},{"key":"3687_CR27","doi-asserted-by":"crossref","unstructured":"Jeong S, Kim K, Chang J, Choi S, Kim SM, Son JS, Lee G, Kim W. Park SMJAotm: development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance. 2020, 8.","DOI":"10.21037\/atm-20-2951"},{"key":"3687_CR28","doi-asserted-by":"crossref","unstructured":"Weng H-Y, Hsueh Y-H, Messam LLM, Hertz-Picciotto, IJAjoe. Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure. 2009, 169:1182\u20131190.","DOI":"10.1093\/aje\/kwp035"},{"key":"3687_CR29","doi-asserted-by":"crossref","unstructured":"Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin MJCG, Hepatology. Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017\u20132020. 2024, 22:1330\u20131332. e1334.","DOI":"10.1016\/j.cgh.2023.11.003"},{"key":"3687_CR30","doi-asserted-by":"crossref","unstructured":"Li H, Ge JJIH, Vasculature. Cardiovascular diseases in China: current status and future perspectives. 2015, 6:25\u201331.","DOI":"10.1016\/j.ijcha.2014.10.002"},{"key":"3687_CR31","doi-asserted-by":"crossref","unstructured":"Noh J, Han K-D, Ko S-H, Ko KS, Park C-YJS. Trends in the pervasiveness of type 2 diabetes, impaired fasting glucose and co-morbidities during an 8-year-follow-up of nationwide Korean population. 2017, 7:46656.","DOI":"10.1038\/srep46656"},{"key":"3687_CR32","doi-asserted-by":"crossref","unstructured":"Sekizawa Y, Konishi Y, Ikari HJS-LS, Health tC-OP, Policy P. Who Are Free from Hypertension, Dyslipidemia, and Diabetes Mellitus in the Middle-Aged and Elderly Population of Japan? 2022:275\u2013302.","DOI":"10.1007\/978-981-16-5727-6_12"},{"key":"3687_CR33","doi-asserted-by":"publisher","first-page":"e0303333","DOI":"10.1371\/journal.pone.0303333","volume":"19","author":"SK Han","year":"2024","unstructured":"Han SK, Seo MJ, Lee T, Kim MY. Effectiveness of the ALT\/AST ratio for predicting insulin resistance in a Korean population: a large-scale, cross-sectional cohort study. PLoS ONE. 2024;19:e0303333.","journal-title":"PLoS ONE"},{"key":"3687_CR34","doi-asserted-by":"crossref","unstructured":"Miwa T, Francisque C, Tajirika S, Hanai T, Imamura N, Adachi M, Horita R, Menezes LJ, Kawaguchi T, Shimizu MJHR. Impact of body fat accumulation on metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease in Japanese male young adults. 2023, 53:691\u2013700.","DOI":"10.1111\/hepr.13906"},{"key":"3687_CR35","doi-asserted-by":"crossref","unstructured":"Omagari K, Kadokawa Y, Masuda JI, Egawa I, Sawa T, Hazama H, Ohba K, Isomoto H, Mizuta Y. Hayashida KJJog, hepatology: fatty liver in non-alcoholic non\u2010overweight Japanese adults: incidence and clinical characteristics. 2002, 17:1098\u2013105.","DOI":"10.1046\/j.1440-1746.2002.02846.x"},{"key":"3687_CR36","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, Kleiner DE, Brunt E, Bugianesi E. Yki-J\u00e4rvinen H: MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158:1999\u20132014. e1991.","journal-title":"Gastroenterology"},{"key":"3687_CR37","doi-asserted-by":"crossref","unstructured":"Gratac\u00f3s-Gin\u00e8s J, Ari\u00f1o S, Sancho-Bru P, Bataller R, Pose EJJR. MetALD: Clinical aspects, pathophysiology and treatment. 2024:101250.","DOI":"10.1016\/j.jhepr.2024.101250"},{"key":"3687_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019shea","year":"2010","unstructured":"O\u2019shea RS, Dasarathy S, McCullough AJ. Diseases PGCotAAftSoL, Gastroenterology tPPCotACo: alcoholic liver disease. Hepatology. 2010;51:307\u201328.","journal-title":"Hepatology"},{"key":"3687_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","volume":"70","author":"M You","year":"2019","unstructured":"You M, Arteel GE. Effect of ethanol on lipid metabolism. J Hepatol. 2019;70:237\u201348.","journal-title":"J Hepatol"},{"key":"3687_CR40","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u201346.","journal-title":"Hepatology"},{"key":"3687_CR41","first-page":"1","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VW-S, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-Tetri BA, Rinella ME. Nonalcoholic fatty liver disease. Nat Reviews Disease Primers. 2015;1:1\u201322.","journal-title":"Nat Reviews Disease Primers"},{"key":"3687_CR42","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.12659\/MSM.901309","volume":"23","author":"SK Kim","year":"2017","unstructured":"Kim SK, Hong S-H, Chung J-H, Cho KB. Association between alcohol consumption and metabolic syndrome in a community-based cohort of Korean adults. Med Sci Monitor: Int Med J Experimental Clin Res. 2017;23:2104.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"3687_CR43","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, Loomba R, Chalasani N, Kowdley K, Hameed B. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385:1559\u201369.","journal-title":"N Engl J Med"},{"key":"3687_CR44","doi-asserted-by":"crossref","unstructured":"Khodami B, Hatami B, Yari Z, Alavian SM, Sadeghi A, Varkaneh HK, Santos HO, Hekmatdoost AJEJCN. Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial. 2022, 76:987\u201394.","DOI":"10.1038\/s41430-022-01081-x"},{"key":"3687_CR45","doi-asserted-by":"crossref","unstructured":"Hallsworth K, Adams LAJJR. Lifestyle modification in NAFLD\/NASH: Facts and Figs.\u00a02019, 1:468\u2013479.","DOI":"10.1016\/j.jhepr.2019.10.008"},{"key":"3687_CR46","doi-asserted-by":"crossref","unstructured":"Hejazi K, Hackett DJJ. Effect of exercise on liver function and insulin resistance markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. 2023, 12:3011.","DOI":"10.3390\/jcm12083011"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03687-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:18:45Z","timestamp":1740399525000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03687-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03687-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Gwangju Institute of Science and Technology (20221201-BR-69-02-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No potential conflict of interest relevant to this article was reported.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"110"}}